| P2093 | author name string | Konstantinos Drosatos | |
| | Ira J Goldberg | |
| | Vassilis I Zannis | |
| | Dimitrios Iliopoulos | |
| | Yaeko Hiyama | |
| P2860 | cites work | Identification of Drosophila MicroRNA targets | Q21146437 |
| | Role of LXRs in control of lipogenesis | Q24290548 |
| | A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 |
| | Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. | Q24542505 |
| | Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter | Q24550969 |
| | Identification of mammalian microRNA host genes and transcription units | Q24562298 |
| | Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta | Q24598068 |
| | The microRNAs of Caenorhabditis elegans | Q24672515 |
| | MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies | Q24681266 |
| | Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways | Q24683796 |
| | Prediction of mammalian microRNA targets | Q27860498 |
| | Argonaute2 is the catalytic engine of mammalian RNAi | Q27860545 |
| | The functions of animal microRNAs | Q27860621 |
| | Unique microRNA molecular profiles in lung cancer diagnosis and prognosis | Q27860631 |
| | MicroRNAs modulate hematopoietic lineage differentiation | Q27860661 |
| | Oncomirs - microRNAs with a role in cancer | Q27860773 |
| | Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 |
| | MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 |
| | MicroRNA signatures in human cancers | Q27860962 |
| | MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 |
| | MicroRNA expression profiles classify human cancers | Q28032481 |
| | microRNAs: tiny regulators with great potential | Q28214699 |
| | Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase | Q28215845 |
| | Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway | Q28236951 |
| | MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells | Q28251177 |
| | Inhibition of translational initiation by Let-7 MicroRNA in human cells | Q28265842 |
| | Direct interaction between USF and SREBP-1c mediates synergistic activation of the fatty-acid synthase promoter | Q28281340 |
| | Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients | Q77318114 |
| | P-bodies take a RISC | Q81927248 |
| | Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary | Q83365755 |
| | Evidence that the AMP-activated protein kinase stimulates rat liver carnitine palmitoyltransferase I by phosphorylating cytoskeletal components | Q28290874 |
| | A pancreatic islet-specific microRNA regulates insulin secretion | Q28292726 |
| | New human and mouse microRNA genes found by homology search | Q28301238 |
| | miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting | Q29547487 |
| | A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes | Q29616620 |
| | Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation | Q29618303 |
| | The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis | Q29618429 |
| | MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure | Q29619548 |
| | Human microRNA (miR29b) expression controls the amount of branched chain alpha-ketoacid dehydrogenase complex in a cell. | Q30351534 |
| | MicroRNA and 3T3-L1 pre-adipocyte differentiation | Q30820724 |
| | microRNAs join the p53 network--another piece in the tumour-suppression puzzle | Q33344707 |
| | AGO1 defines a novel locus of Arabidopsis controlling leaf development. | Q33368444 |
| | Lipotoxic diseases | Q34111950 |
| | Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. | Q34302040 |
| | Dicing and slicing: the core machinery of the RNA interference pathway | Q34458132 |
| | Molecular processes during fat cell development revealed by gene expression profiling and functional annotation | Q34481070 |
| | How do microRNAs regulate gene expression? | Q34573729 |
| | The microRNA world: small is mighty | Q35559723 |
| | Nonalcoholic fatty liver disease and the metabolic syndrome | Q36180393 |
| | Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents | Q36183590 |
| | Current perspectives in intronic micro RNAs (miRNAs). | Q36287969 |
| | T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer | Q36403598 |
| | microRNA-mediated silencing inside P-bodies | Q36688270 |
| | Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression | Q37280624 |
| | A dominant negative form of the transcription factor c-Jun affects genes that have opposing effects on lipid homeostasis in mice | Q37350730 |
| | Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice | Q38323956 |
| | Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway | Q38504286 |
| | Inhibition of breast cancer cell growth in vitro and in vivo: effect of restoration of Wwox expression | Q40187900 |
| | The role of AMP-activated protein kinase in the action of ethanol in the liver | Q40485116 |
| | Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis | Q43542965 |
| | Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities | Q43552270 |
| | MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease | Q43818989 |
| | NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome | Q43875846 |
| | Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease | Q44934521 |
| | Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production | Q46427847 |
| | Short-term overexpression of DGAT1 or DGAT2 increases hepatic triglyceride but not VLDL triglyceride or apoB production | Q51793198 |
| | Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues | Q51958786 |
| | Preliminary Assessment of the Impact of MicroRNA-Mediated Regulation on Coding Sequence Evolution in Mammals | Q59303881 |
| | Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice | Q71757386 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| | microRNA | Q310899 |
| P304 | page(s) | 1513-23 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Journal of Lipid Research | Q6295449 |
| P1476 | title | MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism | |
| P478 | volume | 51 | |